Leaderna

Leaderna focuses on the field of oligonucleotide new drugs, and through independent and collaborative development, it advances new drugs targeting metabolism, cardiovascular and cerebrovascular diseases, chronic inflammation, and tumor immunology, rapidly moving oligonucleotide new drugs into clinical and commercialization stages.